Sec Form 3 Filing - Luo Yuling @ Alamar Biosciences, Inc. - 2026-04-16

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Luo Yuling 2. Issuer Name and Ticker or Trading Symbol Alamar Biosciences, Inc. [ ALMR] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Executive Officer (Last) (First) (Middle) C/O ALAMAR BIOSCIENCES, INC., 47071 BAYSIDE PARKWAY 3. Date of Earliest Transaction (MM/DD/YY) 04/16/2026 (Street) FREMONT, CA94538 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Class B Common Stock 113,051 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Class A Common Stock ( 1 ) ( 1 ) ( 1 ) Class B Common Stock 1,020,742 D Class A Common Stock ( 1 ) ( 1 ) ( 1 ) Class B Common Stock 1,224,152 I By Spouse Founders Preferred Stock ( 1 ) ( 1 ) ( 1 ) Class B Common Stock 366,004 D Series A-1 Preferred Stock ( 2 ) ( 2 ) ( 2 ) Class B Common Stock 364,268 D Stock Option (Right to Buy) $ 2.51 ( 3 ) 02/15/2027 Class B Common Stock 266,311 D Stock Option (Right to Buy) $ 2.51 ( 3 ) 02/15/2027 Class B Common Stock 25,310 D Stock Option (Right to Buy) $ 1.53 ( 4 ) 01/17/2033 Class B Common Stock 23,986 D Stock Option (Right to Buy) $ 1.53 ( 3 ) 04/24/2033 Class B Common Stock 20,023 D Stock Option (Right to Buy) $ 3.34 ( 5 ) 04/16/2034 Class B Common Stock 27,700 D Stock Option (Right to Buy) $ 3.34 ( 6 ) 01/15/2035 Class B Common Stock 1,033,912 D Stock Option (Right to Buy) $ 3.34 ( 7 ) 01/15/2035 Class B Common Stock 37,086 D Stock Option (Right to Buy) $ 7.6 ( 8 ) 01/14/2036 Class B Common Stock 42,334 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Luo Yuling C/O ALAMAR BIOSCIENCES, INC. 47071 BAYSIDE PARKWAY FREMONT, CA94538 X Chief Executive Officer Signatures /s/ Justin J. McAnear, Attorney-in-Fact 04/16/2026 Signature of Reporting Person Date

Explanation of Responses:

( 1 ) Each share of Class A Common Stock and Founders Preferred Stock is convertible into shares of Class B Common Stock on a 1-for-1 basis, at the holder's election, and will automatically convert into shares of Class B Common Stock immediately prior to the closing of the Issuer's initial public offering. The Class A Common Stock has no expiration date. ( 2 )The preferred stock is convertible into shares of Class B Common Stock on a 1-for-2.418 basis, at the holder's election, and will automatically convert into shares of the Issuer's common stock upon the closing of the initial public offering pursuant to their terms. The preferred stock has no expiration date. ( 3 )Fully vested. ( 4 )The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2023, subject to the reporting person's continuous service as of each such vesting date. ( 5 )The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2024, subject to the reporting person's continuous service as of each such vesting date. ( 6 )The shares subject to the option vest in equal monthly installments over 48 months measured from January 16, 2025, subject to the reporting person's continuous service as of each such vesting date. ( 7 )The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2025, subject to the reporting person's continuous service as of each such vesting date. ( 8 )The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2026, subject to the reporting person's continuous service as of each such vesting date.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.